Dover Advisors »

iShares NASDAQ Biotechnology Index shares owned by Dover Advisors

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Dover Advisors from 13F filings

Historical chart of Dover Advisors investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Dover Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Dover Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $382k 2.8k 137.22
2023-09-30 $310k 2.5k 122.44
2023-06-30 $321k 2.5k 126.96
2023-03-31 $327k 2.5k 129.16
2022-12-31 $332k 2.5k 131.29

More positions owned by Dover Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Udr (UDR)
Eaton Corp SHS (ETN)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Kla Corp Com New (KLAC)
Raytheon Technologies Corp (RTX)
Abbott Laboratories (ABT)
Lowe's Companies (LOW)
Palo Alto Networks (PANW)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pepsi (PEP)

View all positions for Dover Advisors

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Farallon Capital Management
Goldman Sachs Group
Morgan Stanley
Citigroup
Elliott Investment Management
Bnp Paribas Arbitrage, Snc
Jpmorgan Chase & Co
UBS Group
Royal Bank of Canada
Susquehanna International
Citadel Advisors
Commerce Bank N A
Wells Fargo & Company
Thrivent Financial for Lutherans

View all funds holding iShares NASDAQ Biotechnology Index